CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC=Breast
5 (424) · $ 20.00 · In stock
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon
Cancers, Free Full-Text
Safety, activity, and molecular heterogeneity following
Preservation of Axillary Lymph Nodes Compared with Complete
Final results from the prospective phase III WSG-ARA trial: impact
PDF] Long-term outcomes of invasive ipsilateral breast tumor
HER2-enriched subtype and novel molecular subgroups drive
Alterations in immune cell phenotype and cytotoxic capacity in
Toxicity of external beam accelerated partial-breast irradiation
You may also like
Related products